Michael C. Ost - Concepedia

Author

Michael C. Ost

Also Known As

M C Ost, M Ost, M. Ost, M.C. Ost, MICHAEL C. OST, Michael C Ost, Michael C. Ost, Michael Cecil Ost, Michael Ost, Michael Ost.

188

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

Children's Hospital of Pittsburgh University of Pittsburgh Medical Center University of Pittsburgh Long Island Jewish Medical Center Northwell Health

About

Michael C. Ost is an author at Children's Hospital of Pittsburgh specializing in medicine, urology, and surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	681
2	Engineering	1	1	58
3	Health Sciences	1	1	35
4	Natural Sciences	1	1	105
5	Biochemistry	1	1	105

Michael C. Ost

Publications

Citations

H-Index

Page 1

	Year	Citations
Neutrophilic myeloid-derived suppressor cells in cord blood modulate innate and adaptive immune responses Nikolaus Rieber, Christian Gille, Natascha Köstlin, Clinical & Experimental Immunology	2013	130
Flagellin Induces Myeloid-Derived Suppressor Cells: Implications for <i>Pseudomonas aeruginosa</i> Infection in Cystic Fibrosis Lung Disease Nikolaus Rieber, Andreas Hector, Ute Graepler-Mainka, The Journal of Immunology	2013	124
Pathogenic Fungi Regulate Immunity by Inducing Neutrophilic Myeloid-Derived Suppressor Cells Nikolaus Rieber, Anurag Singh, Hasan Halit Öz, Cell Host & Microbe	2015	119
Multi-Institutional Review of Outcomes of Robot-Assisted Laparoscopic Extravesical Ureteral Reimplantation Gwen M. Grimsby, Moira Dwyer, Micah A. Jacobs, The Journal of Urology	2014	118
C-terminal Hsp-interacting protein slows androgen receptor synthesis and reduces its rate of degradation Christopher Cardozo, Charlene Michaud, Michael C. Ost, Archives of Biochemistry and Biophysics Signal TransductionBiochemistryG Protein-coupled ReceptorMedicineNatural Sciences	2003	105
A 20-Year Experience With Percutaneous Resection of Upper Tract Transitional Carcinoma: Is There an Oncologic Benefit With Adjuvant Bacillus Calmette Guérin Therapy? Ardeshir R. Rastinehad, Michael C. Ost, Brian A. VanderBrink, Urology Percutaneous Resection20-Year ExperienceSurgical OncologyMedicineSurgery	2008	99
<i>First Prize (Tie):</i> Hemorrhage Following Percutaneous Renal Surgery: Characterization of Angiographic Findings Lee Richstone, Ernesto Reggio, Michael C. Ost, Journal of Endourology	2008	98
Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors Andrea Ferrari, Ines B. Brecht, Gemma Gatta, European Journal of Cancer Paediatric AgeTumoral PathologyMedicineRare CancersPediatrics	2019	91
Selective Arterial Prostatic Embolization (SAPE) for Refractory Hematuria of Prostatic Origin Ardeshir R. Rastinehad, Drew M. Caplin, Michael C. Ost, Urology UrologyRefractory HematuriaProstatic OriginBenign Prostatic HyperplasiaProstatic Disease	2008	83
Laparoscopic pyeloplasty versus antegrade endopyelotomy: Comparison in 100 patients and a new algorithm for the minimally invasive treatment of ureteropelvic junction obstruction Michael C. Ost, Jonathan D. Kaye, Marc J. Guttman, Urology Laparoscopic Pyeloplasty VersusLaparoscopyUrologyMinimally Invasive ProcedurePelvic Reconstructive Surgery	2005	82

Page 1